Contineum Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Contineum Therapeutics, Inc. has filed 189 SEC EDGAR filings since 13 Dec 2023

SEC filing history

Showing 151-175 of 189 matching filings.

Per page
25
Current page
7
SC 13G File 005-94496

SC 13G filing

Filing date
15 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94496

SC 13G

Filing date
15 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Apr 2024
Reporting date
09 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94496

SC 13G filing

Filing date
10 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Apr 2024
Reporting date
09 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42001

8-K

Filing date
09 Apr 2024
Reporting date
09 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-278580

S-8

Filing date
09 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-278003

424B4

Filing date
08 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-278003

EFFECT filing

Filing date
04 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-42001

CERT filing

Filing date
04 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-42001

8-A12B

Filing date
02 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .